SCHEMBL28092192

SCHEMBL28092192

CCCN(c1ccc(S(N)(=O)=O)cc1[N+](=O)[O-])C1CCNCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
MAPT P10636 6/20 0.43
PKM P14618 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
VCAM1 P19320 2/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 4/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH3A1 P30838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956646 0.91 CA2 (0.46) TDP1CA2CA12CA1CA9
SCHEMBL1960063 0.89 CA2 (0.44) TDP1CA2CA12CA1CA9
SCHEMBL1956266 0.89 VCAM1 (0.43) TDP1CA2CA12CA1CA9
SCHEMBL1958846 0.87 CA2 (0.42) TDP1CA2CA12CA1CA9
SCHEMBL1959371 0.86 CA2 (0.45) TDP1CA2CA12CA1CA9
SCHEMBL1958639 0.85 CA2 (0.41) TDP1CA2CA12CA1CA9
SCHEMBL1866518 0.84 CA2 (0.43) TDP1CA2CA12CA1CA9
SCHEMBL1700227 0.84 CA2 (0.43) TDP1CA2CA12CA1CA9
SCHEMBL1958484 0.84 CA2 (0.43) TDP1CA2CA12CA1CA9
SCHEMBL1866666 0.83 CA2 (0.42) TDP1CA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008466-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2018-12-14 CN disclosed
CN-106397418-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE公司 2017-02-15 CN disclosed
CN-106008466-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 艾伯维公司 2016-10-12 CN disclosed
CN-102307622-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2016-08-17 CN disclosed